HANNAH KESLER: Open Payments
NPI 1255805099 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,246 in 106 payments from 13 companies in 2025. Trend: 2023 $2,301 · 2024 $1,147 · 2025 $2,246
Food & beverage: $2,246
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $593 |
| Otsuka America Pharmaceutical, Inc. | 12 | $396 |
| Vanda Pharmaceuticals Inc. | 14 | $370 |
| ABBVIE INC. | 23 | $223 |
| E.R. Squibb & Sons, L.L.C. | 5 | $113 |
| Axsome Therapeutics, Inc. | 4 | $107 |
| Lundbeck LLC | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Janssen Pharmaceuticals, Inc | 4 | $75 |
| Alkermes, Inc. | 3 | $70 |
Products named: CAPLYTA, REXULTI, FANAPT, VRAYLAR, COBENFY, Auvelity, TRINTELLIX, SPRAVATO.
Industry payments across AL — which companies pay providers there.
